Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adherens junction 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
2 Adherens junction 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
3 Alcoholism 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
4 Alcoholism 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
5 Alcoholism 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
6 Alcoholism 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
7 Alcoholism 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
8 Alcoholism 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
9 Alcoholism 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
10 Amphetamine addiction 💬
1件: DRD1 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
11 Amphetamine addiction 💬
1件: DRD1 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
12 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
13 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
14 Breast cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
15 Breast cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
16 Breast cancer 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
17 Breast cancer 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
18 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
19 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
20 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
21 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
22 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
23 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
24 cAMP signaling pathway 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
25 cAMP signaling pathway 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
26 cAMP signaling pathway 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
27 cAMP signaling pathway 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
28 cAMP signaling pathway 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
29 cAMP signaling pathway 💬
3件: SSTR1, SSTR2, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
30 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
31 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
32 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
33 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
34 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
35 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
36 Chemical carcinogenesis - receptor activation 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
37 Chemical carcinogenesis - receptor activation 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
38 Choline metabolism in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
39 Choline metabolism in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
40 Cocaine addiction 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
41 Cocaine addiction 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
42 Cocaine addiction 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
43 Cocaine addiction 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
44 Cocaine addiction 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
45 Cocaine addiction 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
46 Cocaine addiction 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
47 Colorectal cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
48 Colorectal cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
49 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
50 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
51 Cushing syndrome 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
52 Cushing syndrome 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
53 Cytokine-cytokine receptor interaction 💬
1件: GHR 💬 D02691 💬 Somatotropin 23件:  2 ,  3 , 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 💬
54 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
55 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
56 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
57 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
58 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
59 Dopaminergic synapse 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
60 Dopaminergic synapse 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
61 Dopaminergic synapse 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
62 Dopaminergic synapse 💬
3件: DRD2, DRD3, DRD4 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
63 Dopaminergic synapse 💬
3件: DRD2, DRD3, DRD4 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
64 EGFR tyrosine kinase inhibitor resistance 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
65 EGFR tyrosine kinase inhibitor resistance 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
66 Endocrine and other factor-regulated calcium reabsorption 💬
1件: ESR1 💬 D00962 💬 Clomifene 1件: 74 💬
67 Endocrine and other factor-regulated calcium reabsorption 💬
1件: ESR1 💬 D07726 💬 Clomifene 1件: 74 💬
68 Endocrine resistance 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
69 Endocrine resistance 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
70 Endocrine resistance 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
71 Endocrine resistance 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
72 Endocytosis 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
73 Endocytosis 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
74 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
75 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
76 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
77 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
78 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
79 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
80 Estrogen signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
81 Estrogen signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
82 Estrogen signaling pathway 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
83 Estrogen signaling pathway 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
84 Focal adhesion 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
85 Focal adhesion 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
86 FoxO signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
87 FoxO signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
88 Gap junction 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
89 Gap junction 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
90 Gap junction 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
91 Gap junction 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
92 Gap junction 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
93 Gap junction 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
94 Gap junction 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
95 Gap junction 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
96 Gap junction 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
97 Gastric acid secretion 💬
1件: SSTR2 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
98 Gastric cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
99 Gastric cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
100 Glioma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
101 Glioma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
102 GnRH secretion 💬
1件: ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
103 GnRH secretion 💬
1件: ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
104 GnRH signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
105 GnRH signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
106 Growth hormone synthesis, secretion and action 💬
1件: GHR 💬 D02691 💬 Somatotropin 23件:  2 ,  3 , 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 💬
107 Growth hormone synthesis, secretion and action 💬
4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
108 Hepatitis C 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
109 Hepatitis C 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
110 Hepatocellular carcinoma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
111 Hepatocellular carcinoma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
112 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
113 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
114 Human cytomegalovirus infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
115 Human cytomegalovirus infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
116 Human papillomavirus infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
117 Human papillomavirus infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
118 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
119 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
120 JAK-STAT signaling pathway 💬
1件: GHR 💬 D02691 💬 Somatotropin 23件:  2 ,  3 , 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 💬
121 JAK-STAT signaling pathway 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
122 JAK-STAT signaling pathway 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
123 JAK-STAT signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
124 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
125 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
126 Melanoma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
127 Melanoma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
128 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
129 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
130 Morphine addiction 💬
1件: DRD1 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
131 Morphine addiction 💬
1件: DRD1 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
132 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
133 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
134 Neuroactive ligand-receptor interaction 💬
3件: DRD2, DRD3, DRD4 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
135 Neuroactive ligand-receptor interaction 💬
3件: DRD2, DRD3, DRD4 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
136 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
137 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
138 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
139 Neuroactive ligand-receptor interaction 💬
1件: GHR 💬 D02691 💬 Somatotropin 23件:  2 ,  3 , 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 💬
140 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00292 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
141 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00975 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
142 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01510 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
143 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01615 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
144 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01632 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
145 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01948 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
146 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02174 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
147 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02591 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
148 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02592 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
149 Neuroactive ligand-receptor interaction 💬
4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
150 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
151 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
152 Oxytocin signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
153 Oxytocin signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
154 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
155 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
156 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
157 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
158 Parkinson disease 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
159 Parkinson disease 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
160 Parkinson disease 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
161 Parkinson disease 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
162 Parkinson disease 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
163 Parkinson disease 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
164 Parkinson disease 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
165 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
166 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
167 Pathways in cancer 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
168 Pathways in cancer 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
169 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
170 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
171 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
172 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
173 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
174 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
175 PI3K-Akt signaling pathway 💬
1件: GHR 💬 D02691 💬 Somatotropin 23件:  2 ,  3 , 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 💬
176 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
177 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
178 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
179 Platinum drug resistance 💬
1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
180 Platinum drug resistance 💬
1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
181 Prolactin signaling pathway 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
182 Prolactin signaling pathway 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
183 Prolactin signaling pathway 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
184 Prolactin signaling pathway 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
185 Prolactin signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
186 Prostate cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
187 Prostate cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
188 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
189 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
190 Proteoglycans in cancer 💬
1件: ESR1 💬 D00962 💬 Clomifene 1件: 74 💬
191 Proteoglycans in cancer 💬
1件: ESR1 💬 D07726 💬 Clomifene 1件: 74 💬
192 Rap1 signaling pathway 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
193 Rap1 signaling pathway 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
194 Rap1 signaling pathway 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
195 Rap1 signaling pathway 💬
1件: DRD2 💬 D00633 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
196 Rap1 signaling pathway 💬
1件: DRD2 💬 D07870 💬 Dopamine 4件:  6 ,  7 , 74, 299 💬
197